In biomarkers, moving from star system to team system
By Anette Breindl
Friday, July 18, 2014
For the time being, the promise of biomarkers has, by and large, not been realized. Although it has been recognized for decades that good biomarkers could greatly improve both resource allocation and patient outcomes, very few biomarkers have sufficient clinical utility to be in widespread use.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.